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Abstract
Background: Engaging all health care providers in tuberculosis (TB) control has been incorporated as an essential
component of World Health Organization’s Stop TB Strategy and the Stop TB Partnership’s global plan 2006-2015.
Ethiopia has a growing private health sector. The objective of the present study was to investigate the role of
private practitioners (PPs) in TB case detection and assess their perspectives on TB treatment delay in Amhara
Region, Ethiopia.
Results: A cross-sectional study among 112 PPs selected from private health facilities (PHF) in the region was
conducted. The study was carried out between May and August 2008 and data was collected using a semi-
structured questionnaire. Group differences were analyzed using one-way Anova test and a p-value of < 0.05 was
considered statistically significant.
In this study, PPs saw a median of 12 TB suspects and 1.5 patients a week. The mean number of TB suspects and
patients seen varied significantly among the different professions with p < 0.009 and p < 0.004, respectively.
Pulmonary TB patients referred by PPs were delayed up to one week before starting treatment at government
health facilities. A 22% increase in the detection of smear-positive TB cases may be achieved by involving all PHFs
in the TB control program in the region. Nineteen percent of the PPs indicated that TB patients’ prior attendance
to non medical health providers resulted in complication of disease and increased treatment delay for TB.
Conclusion: PPs manage a substantial number of TB suspects and patients in Amhara Region, Ethiopia. The GHF
delay observed among TB patients referred by PPs to GHF is unnecessary. Expanding PPM-DOTS in the region and
improving the quality of TB care at both government and private health facilities reduces treatment delay and
increases TB case detection.
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Background
In most resource-poor countries the government has had
the sole responsibility for the prevention and control of
diseases of public health importance such as tuberculosis
(TB) [1]. However, health services in general are rendered
by both government and private health sectors. Recently,
the World Health Organization (WHO) recognized that
the global target of detecting 70% of all new TB cases is
not likely to be met unless current efforts are strength-
ened by including important stakeholders in TB control
[2]. Engaging all health care providers in TB control has
thus been incorporated as an essential component of
WHO’s new Stop TB Strategy and the Stop TB Partner-
ship’s global plan 2006-2015 [2].
Private practitioners’ (PPs) involvement in TB control
has shown significant results in terms of case detection
[1,3]. For example, several studies from India have
demonstrated an increase in case detection ranging
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from 10% to 60% in private public mix (PPM) projects
[4]. In addition, PPM substantially reduced the financial
burden on patients and facilitated access to quality TB
care [5].
TB case detection is very low throughout Ethiopia [6].
In 2008, the national smear-positive case detection rate
(CDR) was estimated at 28%. In Amhara Region, the
CDR was estimated at 21.5% in the same year [7] indi-
cating an urgent need to utilize all the available oppor-
tunities in order to increase TB case detection and meet
the 70% target as set by WHO.
Ethiopia has a growing private health sector. For many
years, only government health facilities (GHFs) practiced
the directly observed treatment short course (DOTS)
strategy. Since 2007, selected private health facilities
(PHFs) have been involved in the PPM-DOTS initiative
[7]. However, despite the increasing number of PHFs,
there is only one study from urban Ethiopia that described
the number of TB patients managed by PPs [8]. Another
study from Ethiopia indicated that treatment was delayed
for TB patients who first visited PHFs [9]. The possible
reasons for this delay have not been explored. Understand-
ing the contribution of PPs in TB control is necessary to
make recommendations that will reduce treatment delay
for TB patients. The aim of this study was to investigate
the role of PPs in TB case detection and assess their per-




This study was conducted in Amhara Regional State which
is the second largest region of Ethiopia. The region is
divided into 11 zonal administrations. During the study
period, there were 3 hospitals, 22 higher and 119 medium
level clinics owned by the private sector in the region [7].
Hospitals and higher level clinics are managed by medical
specialists and general medical practitioners (GPs) while
medium level clinics are managed by GPs or health offi-
cers (HOs). Since 2008, 35 PHFs have been involved in
PPM-DOTS in the region [7,10]. At the time of this study,
the region also had 17 hospitals, 674 health centers and
2750 health posts owned by the government [7].
Study design
A cross-sectional study was conducted between May
and August, 2008. All PHFs with TB diagnostic facilities
in Amhara Region were eligible for the study. Most
PHFs had one PP who was the owner and the responsi-
ble health worker for the diagnosis and treatment of TB.
But in the major towns of the region, there were 1-3
PPs/PHFs involved in the diagnosis and treatment of
TB. From each PHF, one participant was enrolled in the
study. Random sampling was applied to select the study
participants in places where more than one PP/PHF was
found.
Definition of variables
Medical providers- are health centers and hospitals with
diagnostic and treatment facilities for TB. The relations
between PHF, GHF and treatment delay are shown in
Figure 1.
Medical specialists- are medical doctors with an MD
degree plus a specialty certificate in internal medicine or
pediatrics.
Data collection and analysis
A semi-structured questionnaire was used to collect
data. The questionnaire was pretested and the inter-
viewers received adequate training before data collection
commenced. Five health officers collected the data. The
questionnaire addressed socio-demographic characteris-
tics, number of TB suspects and patients managed by
PPs and their perspectives on TB treatment delays. The
interviewees were medical specialists, GPs and HOs.
Data was analyzed using SPSS version 16. After data
entry and cleaning, proportions were computed and
group differences were analyzed using one-way Anova
tests. A p-value of < 0.05 was considered statistically
significant.
We also conducted reviews of annual Tuberculosis
and Leprosy Control Program (TBLCP) report, TBLCP
guidelines [11] and held in-depth interviews with the
TBLCP team leader and TBLCP experts at the regional
level.
The study was approved by the Regional Committee
for Medical Research Ethics in Eastern Norway (REK
Øst), and the Ethiopian Science and Technology Agency
in Addis Ababa, Ethiopia. Informed consent was taken
from all study participants before the study was
conducted.
Results
Characteristics of study participants
Among 144 PPs eligible for the study, a total of 112
(77.7%) PPs participated in the study. The vast majority,
110 (98.2%), were males. The mean age was 37.8 years.
The median years of medical practice was 7.5 years
(inter quartile-range [IQR] [3,10] (Table 1).
Case detection
In this study, PPs had seen a significant number of
smear-positive TB patients and suspects in their respec-
tive facilities. The median number of smear-positive
cases detected per week was 1.5 (IQR 1, 2). Eighty four
(75%) of the respondents diagnosed 1-3 smear-positive
cases per week (Table 2). The median number of TB
suspects detected per week was 12 (IQR 8, 20). The
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mean number of TB suspects and smear-positive cases
identified varied significantly between the different PPs’
professions with p < 0.009 and p < 0.004, respectively
(Table 3).
Perspectives on treatment delays
Patient’s delay, i.e. the period from the onset of TB
symptoms until the first visit to a medical provider, was
estimated at 2-4 months by 88 (78%) of the PPs. Eleven
(10%) of the PPs estimated patient’s delay to be less
than a month and the remaining 13 (12%) estimated
patient’s delay ranging from 4 months to years. The
major reasons for patient’s delay were perceived to be
due to low awareness of TB among patients, lower/no
access to medical services, self treatment and poverty.
The PHF delay was estimated within the range of
2 days to 15 days for smear-positive pulmonary TB
(PTB) patients by 79% of the study participants, and the
rest 21% of the respondents estimated a PHF delay ran-
ging from 16 days to 21 days. PHF delay was also esti-
mated for smear-negative PTB patients among eighteen
PPs that had smear microscopy and x-ray facilities for
TB. Accordingly, 12 (67%) of the PPs estimated a PHF
delay of 15 days to 30 days for smear-negative PTB
patients. The remaining 6 PPs (33%) estimated PHF
delay to be more than 30 days. The reasons for the PHF
delays greater than 30 days were perceived to be due to
missed appointment dates by patients, incorrect diagno-
sis, lack/shortage of laboratory facilities and absence of
laboratory technicians.
According to 77 (69%) of the respondents, TB patients
delayed after they were referred from PHFs to the GHF
for treatment. The mandatory repeat smear microscopy
exam policy at the GHFs was the major reason for 2-3
days delay before starting treatment. The condition was
worse for patients who were referred on Fridays. Since
Saturday and Sunday are not regular working days,
patients had to wait until Monday for the repeat smear
microscopy at the GHF. According to the respondents,
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Figure 1 Treatment delay: the delay period from the start of symptoms of TB until first start of treatment. Private health facility (PHF)
delay: the delay period from first visit of a TB patient to a PHF until first diagnosis of TB is made at PHF. Government health facility (GHF) delay:
the delay period from first time a TB patient referred from PHF reported to GHF until treatment is initiated at GHF.
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Profession




1-5 years 54 (48.2)
6-10 years 38 (33.9)
> 10 Years 20 (17.9)
Medical specialists: are medical doctors with an MD degree plus a specialty
certificate in internal medicine or pediatrics.
GPs: General practitioners are practitioners with a first degree in medicine.
They are authorized to provide clinical services to patients presenting at
hospitals and higher or mid-level clinics.
HO: Health Officers are health professionals with a first degree in public
health. They have adequate clinical training and are authorized to provide
clinical services to patients presenting at mid-level clinics.
Table 2 Number of TB suspects and smear-positive cases
seen by PPs per week
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these patients could experience a delay of up to one
week after referral before starting treatment. Collabora-
tion with government
Most of the PPs reported that their working relation-
ship with the government has improved. The recent
progress made in terms of commencing PPM-DOTS in
selected PHFs in the region has been considered a posi-
tive step towards strengthening good collaboration. PPs
were also asked about the types of measures needed to
reduce TB treatment delay in the region. The majority
stated that the government health workers must respect
the PPs professionally, and almost all suggested that
PHFs should be fully authorized to manage TB patients.
In addition, uninterrupted supply of diagnostic reagents
and supplies, different recording and reporting formats,
and establishing a coordinating committee including pri-
vate and government representatives were important
interventions needed to strengthen collaboration and
provide quality care to TB patients.
In this study, 19 (17%) of the respondents expressed a
concern over the growing involvement of non medical
providers in TB care. According to these respondents, a
number of TB suspects and patients visited non medical
providers before they reported to a medical facility for
their symptoms. In addition, many patients on anti-TB
regimens were being advised by non medical providers to
stop their medication and start herbal or other traditional
remedies. Most of the patients followed the advice of the
non medical providers, their conditions worsened and
thereafter reported to the PHFs for better management.
Discussion
Following the WHO-recommended strategy of engaging
all health providers in TB care, PPM-DOTS initiatives
have been expanded as an essential tool of improving
TB case detection in many high TB burden countries. In
this study, the role of PPs with respect to TB case detec-
tion was investigated. The results showed that the med-
ian number of TB suspects and patients seen was high
indicating that PPs were potential sources of health care
for TB patients in the study region. Our finding is
higher than that reported in Indonesia [12] and Pakistan
[13] but lower than that in the Philippines [14].
The mean number of TB suspects and patients seen
by PPs varied according to profession of the practi-
tioner. More cases were seen by specialist doctors. The
reason could be that medical specialists in the study
region work in hospitals and higher level clinics where
the patient load is high. In another study, medical spe-
cialists were also found to have seen more cases com-
pared to other PPs [12].
Previous studies have shown that TB patients attending
PHFs were significantly delayed before starting treatment
[9,15-17]. In our study, TB patients referred from PHFs
to GHFs were reported to have been delayed up to one
week before starting treatment. The main reason for the
delay was a result of the mandatory repeat sputum smear
microscopy exam policy at the GHF. This has serious
implications for TB control. The delay caused by manda-
tory repeat examinations may worsen the patient’s illness,
increase the risk of further transmission and incur extra
costs for the patient. We therefore suggest that the gov-
ernment should look into the possibility of providing
routine health service for TB patients during weekends
so that those referred from PPs receive timely diagnosis
and treatment service. This may reduce GHF delay and
extra cost incurred by patients due to the unnecessary
delay.
The PHF delay was estimated within the range of 2 days
to 15 days for smear-positive PTB patients. This is contra-
dictory to the findings of a previous study [9]. Given the
long course of TB disease progression and other factors
such as the initial prescription of broad spectrum antibio-
tics for TB suspects, it is likely that the PHF delay in our
study was underestimated. Also, when we look at the PPs’
perception about the magnitude of and factors for
patient’s delay, a majority of the PPs perceived that the
patient’s delay would be estimated at 2-4 months. The
major factor for the delay was perceived as lack of knowl-
edge of TB among patients and may generally imply
blame to the patient. In contrast, many delay studies that
focused on TB patients’ perspectives have indicated that
the major factor for treatment delay is a “vicious cycle” of
repeated visits to the same level of health care suggesting
that medical providers are to blame for the delay [18,19].
We recommend that a forum should be organized to
Table 3 Analyses of mean difference for the number of TB suspects and smear-positive TB cases identified by the
different professions of PPs
Profession n (%) TB cases
mean (95% CI)
P-value n (%) TB suspects
mean (95% CI)
p-value
Medical Specialists 18 (16.1) 3.3 (1.9, 4.7) 0.004 18 (16.1) 24 (14.1, 34) 0.009
GP 50 (44.6) 2.2 (1.4, 3.1) 50 (44.6) 16 (12.8, 22.1)
HO 44 (39.3) 1.1 (.9, 1.3) 44 (39.3) 12 (10.1, 14.0)
112 112
CI: confidence interval
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discuss the available evidence on treatment delay in TB
among private and government health workers.
In this study, a considerable proportion of PPs indicated
that many TB patients visited non medical health provi-
ders before reporting to PHFs. According to WHO, invol-
ving all health providers in TB control is one of the
strategies that will increase TB case detection [2]. How-
ever, non medical health providers in this study were
perceived to have participated in a manner that compro-
mised the TB control effort. This is serious as it may con-
tribute to the transmission of drug resistant TB in the
region. A mechanism should be devised to involve non
medical providers at an appropriate level and with a
clearly defined role in TB control efforts. Additional stu-
dies investigating the role of non medical providers in the
management of TB in the region are warranted.
Our review of the Amhara Regional Health Bureau
report showed that 35 PHFs were participating in PPM-
DOTS [7]. Taking all PHFs with TB diagnostic facilities in
the region into account, the participation of PHFs in
PPM-DOTS was 24%. This indicates that the involvement
of PHFs in PPM-DOTS in the study region was low.
Our results indicate that a median number of 12 TB
suspects were seen per week. All PPs in the region may
thus see a total of 72,576 TB suspects in one year. In 2
previous studies, the prevalence of smear-positive TB in
urban and rural Ethiopia was estimated at 13% [20] and
3.8% [21], respectively. By using a mean prevalence of
8.4% from the two studies as a smear-positive TB preva-
lence estimate for the study region, a total of 6,096
smear-positive cases may be detected among the
expected 72,576 TB suspects in the region. The study
region has a population of 17.2 million [22], and a
smear-positive TB incidence of 163/100,000 population
[6]. This means that a total of 28,036 new cases may be
expected per year. Hence, taking the above information
into our calculation, the region may achieve a 22%
increase in the detection of smear-positive TB cases by
involving all PHFs in PPM-DOTS.
This study has some limitations. PPs were asked retro-
spectively to state the number of TB suspects and patients
seen in their practice. This data may be influenced by
recall bias. A prospective recording and observation would
have provided an indication as to whether or not the PPs’
reported estimates genuinely reflected the actual number
of patients and suspects seen. Such a study was not within
the scope of our limited resources. However, the PPs were
asked to state the number of cases seen per week rather
than per month or year in an effort to shorten the time
gap and obtain the most correct recall data.
The study may also be subject to selection bias.
Among all PHFs eligible for the study, 32 (22%) of them
did not participate mainly because we could not find
them despite our visits. However, even if we were not
able to include all PHFs eligible for the study, majority
of the PHFs that were actively rendering service to the
population in the region were included from all admin-
istrative levels (zones and districts) in the region. Thus,
we believe that the possibility of selection bias in this
study is reduced.
Conclusions
Our findings indicate that there is a huge potential for
TB control in Amhara Region, Ethiopia. PPs see a large
number of TB suspects and patients in the region. The
GHF delay observed among TB patients referred by PPs
to GHF is unnecessary, and is one of the reasons for
increased treatment delay among TB patients seeking
initial medical attention from PPs. More PHFs should
thus be involved in PPM-DOTS in order to reduce
treatment delay and increase case detection of TB in the
region.
Abbreviations
CDR: case detection rate; DOTS: directly observed treatment short course;
GHFs: government health facilities; GPs: general medical practitioners; HOs:
health officers; IQR: inter quartile-range; PHFs: private health facilities; PPs:
private practitioners; PTB: pulmonary tuberculosis; REK Øst: Regional
Committee for Medical Research Ethics in Eastern Norway; TB: tuberculosis;
TBLCP: Tuberculosis and Leprosy Control Program; PPM: private public mix;
WHO: World Health Organization.
Acknowledgements
The authors would like to thank University of Oslo and the Research Council
of Norway, GLOBVAC programme (grant 192468/S50) for funding this study.
We are grateful to the Amhara Regional State Health Bureau in Amhara
Region for facilitating the study. We also thank all private practitioners for
their willingness to participate in the study.
Author details
1Norwegian Institute of Public Health, Postbox 4404, Nydalen 0403, Oslo,
Norway. 2Institute of Health and Society, Section for International Health,
Faculty of Medicine, University of Oslo, Norway. 3Amhara Regional State
Health Bureau, P.O.Box 495, Bahir Dar, Ethiopia.
Authors’ contributions
SAY conducted the data collection. SAY, GAB and CHH performed the data
analysis. SAY drafted the manuscript. The three authors edited and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 18 April 2011 Accepted: 11 August 2011
Published: 11 August 2011
References
1. Uplekar M: Involving private health care providers in delivery of TB care:
global strategy. Tuberculosis 2003, 83:156-164.
2. WHO: The Stop TB strategy.[http://www.who.int/tb/strategy/en/], [accessed
2010 Jun 03].
3. Uplekar M, Raviglione M, Pathania V: Private practitioners and public
health: weak links in tuberculosis control. Lancet 2001, 358:912-916.
4. Public-Private Mix for DOTS: Towards scaling up. Report from the 3rd
meeting of the PPM Subgroup for DOTS expansion. WHO/HTM/TB/
2005.356 Geneva: World Health Organization; 2005.
5. Floyd K, Arora VK, Murthy KJR, Lönnroth K, Singla N, Akbar Y, Zignol M,
Uplekar M: Cost and cost-effectiveness of public and private sector
Yimer et al. BMC Research Notes 2011, 4:285
http://www.biomedcentral.com/1756-0500/4/285
Page 5 of 6
collaboration in tuberculosis control: evidence from India. Bulletin of
WHO 2006, 84:437-45.
6. World Health Organization: Global tuberculosis control-epidemiology,
strategy and financing: profiles of high burden countries. Annual report
NO. WHO/HTM/TB/2008.393. Geneva 2008.
7. Amhara Regional State Health Bureau: Annual Health Service Report. Bahir
Dar, Ethiopia 2008.
8. Shimeles E, Assefa A, Yamuah L, Tilahun H, Engers H: Knowledge and
practice of private practioners in TB control in Addis Ababa. Int J tubrc
lung dis 2006, 10:172-1177.
9. Yimer S, Bjune G, Alene G: Diagnostic and treatment delay among
pulmonary tuberculosis patients in Ethiopia: a cross-sectional study. BMC
Infect Dis 2005, 5:112.
10. The United States Agency for International Development (USAID): Final
evaluation: The private sector program in Ethiopia. 2009 [http://www.
ghtechproject.com/Attachment.axd?ID=65d87be9-5166-4011].
11. National Tuberculosis and Leprosy Prevention and Control Program,
Manual. Addis Ababa, Ethiopia: Ministry of Health; 2002, 27-33.
12. Mahendradhata Y, Utarini A, Lazuardi U, Boelaert M, Stuyft PV: Private
practitioners and tuberculosis case detection in Jogjakarta, Indonesia:
actual role and potential. Tropical Medicine and International Health 2007,
12:1218-1224.
13. Ahmed M, Fatmi Z, Ali S, Ahmed J, Ara N: Knowledge, attitude and
practice of private practioners regarding TB-DOTS in a rural district of
Sindh, Pakistan. J Ayub Med Coll Abbottabad 2009, 21.
14. Portero JL, Rubio M: Private practitioners and tuberculosis control in the
Philippines: strangers when they meet? Tropical Medicine and International
Health 2003, 8:329-335.
15. Hooi LN: Case-finding for pulmonary tuberculosis in Penang. Med J
Malaysia 1994, 49:223-230.
16. Masjedi MR, Cheragvandi A, Hadian M, Velayati AA: Reasons for delay in
the management of patients with pulmonary tuberculosis. East Mediterr
Health J 2002, 8:324-329.
17. Ward J, Siskind V, Konstantinos A: Patient and health care system delays
in Queensland tuberculosis patients, 1985-1998. Int J Tuberc Lung Dis
2001, 5:1021-1027.
18. Storla DG, Yimer S, Bjune GA: A systematic review of delay in the
diagnosis and treatment of tuberculosis. BMC Public Health 2008, 8:15.
19. Yimer S, Holm-Hansen C, Yimaldu T, Bjune G: Health care seeking among
pulmonary tuberculosis suspects and patients in rural Ethiopia: a
community-based study. BMC Public Health 2009, 9:454.
20. Demissie M, Zenebre B, Berhane Y, Lindtjørn B: A rapid survey to
determine the prevalence of smear-positive tuberculosis in Addis Ababa.
Int J Tuberc Lung Dis 2002, 6:580-584.
21. Yimer S, Holm-Hansen C, Yimaldu T, Bjune G: Evaluating an active case-
finding strategy to identify smear-positive tuberculosis in rural Ethiopia.
Int J Tuberc Lung Dis 2009, 13:1399-404.
22. Central Statistics Authority: The 2007 population and housing census of
Ethiopia: Results for Amhara Region, Addis Ababa, Ethiopia. 2009.
doi:10.1186/1756-0500-4-285
Cite this article as: Yimer et al.: The perspective of private practitioners
regarding tuberculosis case detection and treatment delay in Amhara
Region, Ethiopia: a cross-sectional study. BMC Research Notes 2011 4:285.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yimer et al. BMC Research Notes 2011, 4:285
http://www.biomedcentral.com/1756-0500/4/285
Page 6 of 6
